Cancer Genetics Inc  

(Public, NASDAQ:CGIX)   Watch this stock  
Find more results for FRANKLYN G. PRENDERGAST
7.83
-0.20 (-2.49%)
Oct 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.80 - 8.03
52 week 6.21 - 20.95
Open 8.03
Vol / Avg. 17,005.00/43,685.00
Mkt cap 78.16M
P/E     -
Div/yield     -
EPS -1.63
Shares 9.70M
Beta     -
Inst. own 39%
Oct 15, 2014
Cancer Genetics Inc at Redchip Virtual Conference
Sep 3, 2014
Cancer Genetics Inc at Barrington Research Fall Investment Conference
Aug 14, 2014
Cancer Genetics Inc at Canaccord Genuity Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -276.96% -187.18%
Operating margin -291.80% -128.01%
EBITD margin - -123.07%
Return on average assets -32.71% -38.60%
Return on average equity -39.94% -115.19%
Employees 61 -
CDP Score - -

Address

2ND FLOOR, 201 ROUTE 17 NORTH
RUTHERFORD, NJ 07070
United States - Map
+1-201-5289200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cancer Genetics, Inc. (CGI) is an early-stage, diagnostic company. The Company focuses on developing and commercializing genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer. These cancers include hematological, urogenital and human papillomavirus (HPV)-associated cancers. It provides its tests and services to oncologists and pathologists at hospitals, cancer centers, and physician offices. In January 2012, the Company received CLIA approval for MatBA-SLL, its microarray for risk stratification in small lymphocytic lymphoma (SLL). The Company develops and produces two types of deoxyribonucleic acid (DNA)-based genomic tests: microarrays and probes. In August 2014, the Company acquired BioServe Biotechnologies (India) Pvt. Ltd.

Officers and directors

John G. Pappajohn Chairman of the Board
Age: 85
Bio & Compensation  - Reuters
Panna L. Sharma President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Edward J. Sitar CPA Chief Financial Officer, Treasurer, Secretary
Age: 53
Bio & Compensation  - Reuters
Jane Houldsworth Ph.D. Vice President - Research & Development
Age: 55
Bio & Compensation  - Reuters
Raju S. K. Chaganti Ph.D. Director
Age: 81
Bio & Compensation  - Reuters
Keith L. Brownlie CPA Independent Director
Age: 61
Bio & Compensation  - Reuters
Edmund M. Cannon Independent Director
Age: 69
Bio & Compensation  - Reuters
Franklyn G. Prendergast M.D., Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Paul Rothman M.D. Independent Director
Age: 56
Bio & Compensation  - Reuters